EUVIMEDEUVIMED entdecken
Crossref

CTHRC1 serves as an indicator in biliary atresia for evaluating the stage of liver fibrosis and predicting prognosis

Zequan Ding, Ruyi Zhang, Wei Zhu, Yao Lu, Zhongxian Zhu, Hua Xie, Weibing Tang

Digestive and Liver Disease · 2025

DOI: 10.1016/j.dld.2024.07.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Zequan Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing 210000, Jiangsu Province, China. Hauptthemen laut MEDLINE: Biliary Atresia, Liver Cirrhosis, Extracellular Matrix Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver fibrosis is a pathological feature of biliary atresia (BA). However, both histological fibrosis stage and existing biomarkers fail to predict prognosis at the time of hepatoportonterostomy (HPE). AIMS: To explore the role of collagen triple- helix repeat containing-1 (CTHRC1) in BA. METHODS: CTHRC1 expression levels were detected and its association with liver fibrosis stage was analyzed in patients with BA. Immunohistochemistry and immunofluorescent analyses were performed to detect the expression and localization of CTHRC1. Epithelial-mesenchymal transition (EMT) and proliferation were analyzed in cholangiocytes treated with recombinant human CTHRC1 protein. Survival analyses were performed to assess the prognostic value of CTHRC1 in patients with BA. RESULTS: CTHRC1 was upregulated in BA, and its expression level was positively correlated with fibrosis-related markers and the severity of liver fibrosis. In liver tissue CTHRC1 was co-localized with CK19 and highly expressed in patients with severe liver fibrosis. Further experiments revealed that CTHRC1 promoted cholangiocyte EMT and proliferation. Additionally, CTHRC1 expression levels at HPE could predict the 2-year native liver survival (NLS). CONCLUSIONS: CTHRC1 promotes the EMT and proliferation of cholangiocytes and indicate the stage of liver fibrosis. The CTHRC1 expression levels can predict outcomes of BA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary AtresiaLiver CirrhosisExtracellular Matrix ProteinsHumansMaleFemalePrognosisBiomarkersEpithelial-Mesenchymal TransitionInfantLiverSeverity of Illness IndexUp-RegulationCell ProliferationPortoenterostomy, Hepatic

Stichwörter der Autor:innen

Biliary atresiaCTHRC1Epithelial-mesenchymal transitionLiver fibrosis

Substanzen

BiomarkersCTHRC1 protein, humanExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing 210000, Jiangsu Province, China.
  • Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing 210000, Jiangsu Province, China. Electronic address: xiehua3955@126.com.
  • Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing 210000, Jiangsu Province, China. Electronic address: twbcn@njmu.edu.cn.

Zitieren

APA

Ding, Z., Zhang, R., Zhu, W., Lu, Y., Zhu, Z., Xie, H., & Tang, W. (2025). CTHRC1 serves as an indicator in biliary atresia for evaluating the stage of liver fibrosis and predicting prognosis. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.07.004

Vancouver

Ding Z, Zhang R, Zhu W, Lu Y, Zhu Z, Xie H, et al. CTHRC1 serves as an indicator in biliary atresia for evaluating the stage of liver fibrosis and predicting prognosis. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.07.004

BibTeX
@article{Ding2025,
  author = {Ding, Zequan and Zhang, Ruyi and Zhu, Wei and Lu, Yao and Zhu, Zhongxian and Xie, Hua and Tang, Weibing},
  title = {CTHRC1 serves as an indicator in biliary atresia for evaluating the stage of liver fibrosis and predicting prognosis},
  journal = {Digestive and Liver Disease},
  year = {2025},
  doi = {10.1016/j.dld.2024.07.004}
}
Kostenlos starten →